Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Lawler

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Current Drug Targets|October 16, 2008
ThrombospondinsJack Lawler
Seminars in Cancer Biology|October 3, 2022
Counter regulation of tumor angiogenesis by vascular endothelial growth factor and thrombospondin-1Jack Lawler
Journal of Cellular and Molecular Medicine|July 9, 2009
Introduction to the tumour microenvironment review seriesJack Lawler
Journal of Cellular and Molecular Medicine|May 11, 2002
Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growthJack Lawler
Blood|September 24, 2016
When is a thrombogenic matrix not thrombogenic?Jack Lawler
Blood|June 5, 2010
Megakaryocytes join the war on cancerJack Lawler
BMC Structural Biology|May 17, 2011
The structure of the Ca²+-binding, glycosylated F-spondin domain of F-spondin - A C2-domain variant in an extracellular matrix proteinKemin Tan, Jack Lawler
Journal of Cell Communication and Signaling|December 22, 2017
Integration of pro- and anti-angiogenic signals by endothelial cellsShideh Kazerounian, Jack Lawler
Journal of Cell Communication and Signaling|October 16, 2009
The interaction of Thrombospondins with extracellular matrix proteinsKemin Tan, Jack Lawler
The International Journal of Biochemistry & Cell Biology|April 20, 2004
Tumor progression: the effects of thrombospondin-1 and -2Jack Lawler, Michael Detmar
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Current Drug Targets|October 16, 2008
ThrombospondinsJack Lawler
Seminars in Cancer Biology|October 3, 2022
Counter regulation of tumor angiogenesis by vascular endothelial growth factor and thrombospondin-1Jack Lawler
Journal of Cellular and Molecular Medicine|July 9, 2009
Introduction to the tumour microenvironment review seriesJack Lawler
Journal of Cellular and Molecular Medicine|May 11, 2002
Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growthJack Lawler
Blood|September 24, 2016
When is a thrombogenic matrix not thrombogenic?Jack Lawler
Blood|June 5, 2010
Megakaryocytes join the war on cancerJack Lawler
BMC Structural Biology|May 17, 2011
The structure of the Ca²+-binding, glycosylated F-spondin domain of F-spondin - A C2-domain variant in an extracellular matrix proteinKemin Tan, Jack Lawler
Journal of Cell Communication and Signaling|December 22, 2017
Integration of pro- and anti-angiogenic signals by endothelial cellsShideh Kazerounian, Jack Lawler
Journal of Cell Communication and Signaling|October 16, 2009
The interaction of Thrombospondins with extracellular matrix proteinsKemin Tan, Jack Lawler
The International Journal of Biochemistry & Cell Biology|April 20, 2004
Tumor progression: the effects of thrombospondin-1 and -2Jack Lawler, Michael Detmar
Pageof 11